FDA– tag –
-
Unicorn Bioscience Report Projects Regenerative Medicine Market to Reach $58.4 Billion in 2026, Scaling to $360 Billion by 2034
Unicorn Bioscience USA Overview Unicorn Bioscience has published a market research report projecting the regenerative medicine market to reach approximately $58.4 billion in 2026, with an anticipated surge to $360 billion by 2034. This g... -
First-in-Human Pluripotent Stem Cell-Derived Neural Stem Cell Therapy for Huntington’s Disease (Regen4HD) Reports Phase 1b/2a Updates at ISSCR 2026
PharmaTimes USA Overview Updates from the first-in-human Phase 1b/2a clinical trial of Regen4HD, a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease, were presented at the ISSCR 2026 Annual Meeting. This lan... -
MSC-Derived Exosomes Emerge as Promising Cell-Free Regenerative Therapies, Driving Active Research in Arthritis, Chronic Wounds, and Inflammatory Diseases
Vertex AI Search USA Overview Mesenchymal Stem Cell (MSC)-derived exosomes are garnering significant attention in regenerative medicine as a cell-free therapeutic alternative, capable of delivering MSCs' potent regenerative and immunomod... -
CRISPR Gene Therapies Expand Beyond Initial FDA Approvals, Advancing to Late-Stage Trials for Diverse Indications
Ubie Doctor's Note USA Overview As of mid-2026, two CRISPR gene therapies, Casgevy (for sickle cell disease and beta-thalassemia) and EDIT-101 (for Leber congenital amaurosis type 10), have received FDA approval, establishing foundationa... -
Assyro AI Offers Intelligent Regulatory Tool for CDMOs, Enabling Automated ICH Guideline Tracking and Rapid Module 3 Document Generation
Assyro AI USA Overview Assyro AI provides an intelligent regulatory tool for CDMOs (Contract Development and Manufacturing Organizations) in CMC/manufacturing roles. This tool assists with automated tracking of ICH quality guidelines, ra... -
Gyros Protein Technologies Streamlines Biotherapeutic Impurity Testing with Automated Immunoassay Platform: Enhancing Reproducibility and Throughput
Bioprocess International (via Gyros Protein Technologies webcast summary) USA Overview Gyros Protein Technologies is addressing impurity testing challenges in biotherapeutic development with its Gyrolab automated immunoassay platform. Th... -
Securecell Unveils APIES Multi-Attribute Analysis Platform for Biopharmaceuticals: Real-time Monitoring of Protein Concentration, Aggregation, and Stability
Securecell Switzerland Overview Securecell has launched APIES, a multi-attribute analysis platform providing comprehensive insights into biopharmaceutical samples. APIES leverages absorbance, intrinsic fluorescence, and scattering to ena... -
Hyperspectral Enhances Bioprocess Visibility with Real-time PAT: Raman Spectroscopy and Chemometrics Enable Non-Invasive Mammalian Cell Culture Monitoring
Hyperspectral (via analytica 2026 presentation) Unknown Overview Hyperspectral has introduced an innovative solution for real-time, non-invasive monitoring of mammalian cell culture processes by combining Raman spectroscopy with chemomet... -
Data Integrity Secured in Automated Bioprocesses: Middleware Ensures FDA 21 CFR Part 11 Compliance with Robust Audit Trails and Real-time Capture
Technology Networks USA Overview Ensuring data integrity in automated bioprocesses is paramount, necessitating compliance with regulatory frameworks like US 21 CFR Part 11 and ALCOA+ principles. Middleware solutions are crucial for preve... -
SNS Insider Analysis: Viral Vector Manufacturing Market Surges as Leading CDMOs Expand Capacity with Advanced AAV and Lentiviral Technologies
SNS Insider India Overview SNS Insider's market overview highlights that the increasing number of gene therapy clinical trials and the reliance on CDMOs are driving growth in the viral vector manufacturing market. Key CDMOs like Fujifilm...
